Please cite:
Dimitra Karagkouni, Maria D. Paraskevopoulou, Serafeim Chatzopoulos, Ioannis S. Vlachos, Spyros Tastsoglou, Ilias Kanellos, Dimitris Papadimitriou, Ioannis Kavakiotis, Sofia Maniou, Giorgos Skoufos, Thanasis Vergoulis, Theodore Dalamagas, Artemis G. Hatzigeorgiou; DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA–gene interactions, Nucleic Acids Research, gkx1141, https://doi.org/10.1093/nar/gkx1141
Bulk download:
We have updated the bulk download module, which simplifies the download process! Please find the new online form by following this link

hsa-miR-1910-5p


Loading... Please wait, this might take a few seconds...



Filters
Interactions: 474, Experiments: (low: , high: , unknown: ) Cell lines: , Tissues: , Publications:
Gene name miRNA name Experiments
throughput
Publications Cell lines Tissues Pred. Score
GOLPH3 hsa-miR-1910-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Pillai MM et al. 2014 IP Mammary Gland BT474 N/A N/A
Location Method Result Regulation Validation Type Source
chr5:32135588-32135606 HITS-CLIP POSITIVE DIRECT TarBase 7.0
PDE4D hsa-miR-1910-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr5:58971201-58971227 HITS-CLIP POSITIVE DIRECT TarBase 7.0
CSNK1A1 hsa-miR-1910-5p low: 0 high: 1 1 1 1 0.472
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Pillai MM et al. 2014 IP Mammary Gland BT474 N/A N/A
Location Method Result Regulation Validation Type Source
chr5:149495662-149495689 HITS-CLIP POSITIVE DIRECT TarBase 7.0
AMOTL2 hsa-miR-1910-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Pillai MM et al. 2014 IP Mammary Gland BT474 N/A N/A
Location Method Result Regulation Validation Type Source
chr3:134355931-134355952 HITS-CLIP POSITIVE DIRECT TarBase 7.0
KPNA1 hsa-miR-1910-5p low: 0 high: 1 1 1 1 0.527
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Pillai MM et al. 2014 IP Mammary Gland BT474 N/A N/A
Location Method Result Regulation Validation Type Source
chr3:122425603-122425631 HITS-CLIP POSITIVE DIRECT TarBase 7.0
FXR1 hsa-miR-1910-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Pillai MM et al. 2014 IP Mammary Gland BT474 N/A N/A
Location Method Result Regulation Validation Type Source
chr3:180970264-180970289 HITS-CLIP POSITIVE DIRECT TarBase 7.0
BBX hsa-miR-1910-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr3:107645888-107645910 HITS-CLIP POSITIVE DIRECT TarBase 7.0
EIF4G1 hsa-miR-1910-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr3:184321306-184321325 HITS-CLIP POSITIVE DIRECT TarBase 7.0
SPCS1 hsa-miR-1910-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr3:52706815-52706841 HITS-CLIP POSITIVE DIRECT TarBase 7.0
RTN4 hsa-miR-1910-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Pillai MM et al. 2014 IP Mammary Gland BT474 N/A N/A
Location Method Result Regulation Validation Type Source
chr2:54972366-54972382 HITS-CLIP POSITIVE DIRECT TarBase 7.0
HDLBP hsa-miR-1910-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr2:241227966-241227985 HITS-CLIP POSITIVE DIRECT TarBase 7.0
MSH6 hsa-miR-1910-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr2:47801112-47801124 HITS-CLIP POSITIVE DIRECT TarBase 7.0
SCP2 hsa-miR-1910-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr1:53049391-53049415 HITS-CLIP POSITIVE DIRECT TarBase 7.0
ICMT hsa-miR-1910-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Pillai MM et al. 2014 IP Mammary Gland BT474 N/A N/A
Location Method Result Regulation Validation Type Source
chr1:6223665-6223685 HITS-CLIP POSITIVE DIRECT TarBase 7.0
KIAA1324 hsa-miR-1910-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Pillai MM et al. 2014 IP Mammary Gland BT474 N/A N/A
Location Method Result Regulation Validation Type Source
chr1:109200758-109200785 HITS-CLIP POSITIVE DIRECT TarBase 7.0
LGALS8 hsa-miR-1910-5p low: 0 high: 1 1 1 1 0.817
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Pillai MM et al. 2014 IP Mammary Gland BT474 N/A N/A
Location Method Result Regulation Validation Type Source
chr1:236548747-236548757 HITS-CLIP POSITIVE DIRECT TarBase 7.0
KDM5B hsa-miR-1910-5p low: 0 high: 1 1 1 1 0.848
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Pillai MM et al. 2014 IP Mammary Gland BT474 N/A N/A
Location Method Result Regulation Validation Type Source
chr1:202733452-202733470 HITS-CLIP POSITIVE DIRECT TarBase 7.0
SSX2IP hsa-miR-1910-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:emetine
Location Method Result Regulation Validation Type Source
chr1:84662470-84662491 HITS-CLIP POSITIVE DIRECT TarBase 7.0
B4GALT2 hsa-miR-1910-5p low: 0 high: 1 1 1 1 0.799
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr1:43990477-43990498 HITS-CLIP POSITIVE DIRECT TarBase 7.0
STMN1 hsa-miR-1910-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr1:25900898-25900913 HITS-CLIP POSITIVE DIRECT TarBase 7.0